FDA Inspection 861316 — Tri-State Biologics Inc.

Tri-State Biologics Inc. — FEI 3009460824

The FDA completed an inspection of Tri-State Biologics Inc. on January 7, 2014 in Secaucus, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 4 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
January 7, 2014
Fiscal Year
2014
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Secaucus, NJ (United States)

Citations

IDCFRDescription
1241721 CFR 1271.260(e)Periodic review of temperatures
1243321 CFR 1271.265(f)Return to inventory--procedures
1245221 CFR 1271.290(d)Recording I.D. code and type of HCT/P
1245321 CFR 1271.290(e)Documenting disposition of each HCT/P